Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2022-06-30
2023-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficiency of a Nurse-led Self-management Education Intervention in Promoting Safety Knowledge and Skills of Patients With Arthritis Treated Par Biologics
NCT02855320
Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity
NCT07277491
L-carnitine Supplementation in Rheumatoid Arthritis Patients
NCT06753565
This Study Aims to Characterize and Compare Patients of Adult-onset RA With Patients of Elderly-onset RA Based on the Clinical Manifestations, Disease Activity, Severity Parameters, and Therapeutic Features
NCT07069088
Effect of Laser Puncture on Rheumatoid Arthritis Patients
NCT04684693
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RA patients recieved biological therapy
RA patients recieved different biological therapy
No interventions assigned to this group
RA patients recieved different DMARDS
RA patients recieved different DMARDS
Biological Drug
Different biological drugs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biological Drug
Different biological drugs
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nesma Mansour Mohamed
Outcomes of different biological therapy on rheumatoid arthritis
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
N M AHM, Specialist
Role: PRINCIPAL_INVESTIGATOR
Sohag faculty of medicine
M M AHM
Role: PRINCIPAL_INVESTIGATOR
Sohag faculty of medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sohag faculty of medicine
Sohag, Sohag Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Soh-Med-22-02-16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.